Explore Survodutide dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Survodutide (BI 456906) is a GLP-1 and glucagon receptor dual agonist developed by Boehringer Ingelheim and Zealand Pharma, studied in obesity and in metabolic dysfunction-associated steatohepatitis (MASH), where the glucagon arm is thought to add direct effects on liver fat and energy expenditure beyond GLP-1-driven appetite suppression. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting Survodutide.
6 Survodutide reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (2 calculations). The median dose across all sessions is 1mg. The most common bacteriostatic water volume is 1mL. The most popular vial size is 10mg (6 sessions).
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.